Inactivation of human immunodeficiency virus by gamma radiation and its effect on plasma and coagulation factors.
The inactivation of HIV by gamma-radiation was studied in frozen and liquid plasma; a reduction of the virus titer of 5 to 6 logs was achieved at doses of 5 to 10 Mrad at -80 degrees C and 2.5 Mrad at 15 degrees C. The effect of irradiation on the biologic activity of a number of coagulation factors in plasma and in lyophilized concentrates of factor VIII (FVIII) and prothrombin complex was examined. A recovery of 85 percent of the biologic activity of therapeutic components present in frozen plasma and in lyophilized coagulation factor concentrates was reached at radiation doses as low as 1.5 and 0.5 Mrad, respectively. As derived from the first-order radiation inactivation curves, the radiosensitive target size of HIV was estimated to be 1 to 3 MDa; the target size of FVIII was estimated to be 130 to 160 kDa. Gamma radiation must be disregarded as a method for the sterilization of plasma and plasma-derived products, because of the low reduction of virus infectivity at radiation doses that still give acceptable recovery of biologic activity of plasma components.
Hiemstra
H
H
Central Laboratory of The Netherlands, Red Cross Blood Transfusion Service, Amsterdam.
Tersmette
M
M
Vos
A H
AH
Over
J
J
van Berkel
M P
MP
de Bree
H
H
D001779:Blood Coagulation Factors / Q000528:radiation effects*; D002851:Chromatography, High Pressure Liquid; D003037:Cobalt Radioisotopes; D005169:Factor VIII / Q000528:radiation effects; D005720:Gamma Rays; D005814:Genes, Viral / Q000528:radiation effects; D006678:HIV / Q000528:radiation effects*; D006801:Humans; D008970:Molecular Weight; D010949:Plasma / Q000382:microbiology*; D011516:Prothrombin / Q000528:radiation effects; D013696:Temperature
D001779:Blood Coagulation Factors; D003037:Cobalt Radioisotopes; D011516:Prothrombin; D005169:Factor VIII